Pathogenesis of diabetic nephropathy

Trends in Endocrinology and Metabolism

Volumn 7, Issue 9, 1996, Pages 320-323

  Chowdhury, T A ^a   Barnett, A H ^a   Bain, S C ^a  

^a UNIVERSITY DEPARTMENT OF MEDICINE   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

DIABETIC NEPHROPATHY; HIGH RISK POPULATION; HISTOPATHOLOGY; HUMAN; HUMAN CELL; HUMAN TISSUE; KIDNEY BLOOD FLOW; KIDNEY FAILURE; PATHOGENESIS; PATHOPHYSIOLOGY; PRIORITY JOURNAL; SHORT SURVEY;

EID: 0030296426     PISSN: 10432760     EISSN: None     Source Type: Journal    
DOI: 10.1016/S1043-2760(96)00152-X     Document Type: Short Survey

References (40)

1. Almdal T, Noorgaard K, Feldt-Rasmussen B, Deckert T: 1994. The predictive value of microalbuminuria in IDDM: a five year follow up study. Diabetes Care 17:120-125.
2. Andersen AR, Christiansen JS, Andersen JK, Kreiner JK, Deckert T: 1983. Diabetic nephropathy in type 1 (insulin dependent) diabetes: an epidemiological study. Diabetologia 25:496-501.
3. Barbosa J, Steffes MW, Sutherland D, Connett JE, Rao V, Mauer M: 1994. Effect of glycemic control on early diabetic renal lesions. JAMA 272:600-606.
4. Björck S, Mulec H, Johnsen SA, Norden G, Aurell M: 1992. Renal protective effect of enalapril in diabetic nephropathy. BMJ 304: 339-343.
5. Bojestig M, Arnqvist HJ, Hermansson G, Karlberg BE, Ludvigsson J: 1994. Declining incidence of nephropathy in insulin-dependent diabetes mellitus. N Engl J Med 330:15-18.
6. Borch-Johnsen K, Andersen JK, Deckert T: 1985. The effect of proteinuria on relative mortality in type 1 diabetes. Am J Med 78: 785-794.
7. Borch-Johnsen K, Norgaard K, Hommel E, et al.: 1992. Is diabetic nephropathy an inherited complication? Kidney Int 41:719-722.
8. Border WA, Noble NA, Yamamoto T, et al.: 1992. Natural inhibitor of transforming growth factor beta protects against scarring in experimental kidney disease. Nature 360: 361-364.
9. Brownlee W, Cerami A, Vlassara H: 1988. Advanced glycosylation end products in tissue and the biochemical basis of diabetic complications. N Engl J Med 318:1315-1321.
10. Crandall JP, Appel JB: 1993. Detection and management of early diabetic nephropathy. Trends Endocrinol Metab 3:232-237.
11. Deckert T, Horowitz I, Kofoed-Enevoldsen A, et al.: 1991. Possible genetic defects in the regulation of glycosaminoglycans in patients with diabetic nephropathy. Diabetes 40:764-770.
12. Dent MT, Tebbs SE, Gonzalez AM, Ward JD, Wilson RM: 1991. Neutrophil aldose reductase activity and its association with established diabetic microvascular complications. Diabet Med 8:439-442.
13. The Diabetes Control and Complications Research Group: 1993. The effect of intensive treatment of diabetes on the development and progression of long term complications in insulin dependent diabetes mellitus. N Engl J Med 329:977-986.
14. Dollery CT, Friedman LA, Hensby CN, et al.: 1979. Circulating prostacyclin may be reduced in diabetes. Lancet 2:1365.
15. Doria A, Warram JH, Krolewski AS: 1994. Genetic predisposition to diabetic nephropathy: evidence for a role of the angiotensin 1 converting enzyme gene. Diabetes 43:690-695.
16. Dunn BR, Ichikawa I, Pfeffer J, Troy JL, Brenner BM: 1986. Renal and systemic hemodynamic effects of synthetic atrial natriuretic peptide in the anaesthetized rat. Circ Res 59: 237-246.
17. Earle K, Walker J, Hill L, Viberti GC: 1990. Familial clustering of cardiovascular disease in patients with insulin dependent diabetes and nephropathy. N Engl J Med 326:673-677.
18. Flyvberg A, Thorlacius-Ussing O, Naeraa R, Ingerslev J, Orskov H: 1988. Kidney tissue somatomedin C and initial renal growth in diabetic and uninephrectomized rats. Diabetologia 31:310-314.
19. Flyvberg A, Frystyk J, Thorlacius-Ussing O, Orskov H: 1989. Somatomedin analogue administration prevents increase in kidney somatomedin C and initial renal growth in diabetic and uninephrectomized rats. Diabetologia 32:261-265.
20. Fukui M, Nakamura T, Ebihara I, Shirato I, Tomino Y, Koide H: 1992. ECM gene expression and its modulation by insulin in diabetic rats. Diabetes 41:1520-1527.
21. Fuller JH, Keen H, Jarrett RJ, et al.: 1979. Haemostatic variables associated with diabetes and its complications. BMJ 292:964-966.
22. Jungmann E, Felber A, Graeber S, Hillmann U, Haak T, Palitzsch K, Usadel K: 1993. Human atrial natriuretic peptide in patients with type 1 diabetes mellitus: is it related to the development of diabetic nephropathy? Clin Invest 71:604-609.
23. Krolewski AS, Laffel LMB, Krolewski M, Quinn M, Warram JH: 1995. Glycosylated hemoglobin and the risk of microalbuminuria in patients with insulin dependent diabetes mellitus. N Engl J Med 332:1251-1255.
24. Marre M, Bernadet P, Gallois Y, et al.: 1994. Relationships between angiotensin I converting enzyme gene polymorphism, plasma levels, and diabetic retinal and renal complications. Diabetes 43:384-388.
25. Mathiesen ER, Hommel E, Giese J, Parving HH: 1991. Efficacy of captopril in postponing nephropathy in normotensive insulin dependent diabetic patients with microalbuminuria. BMJ 303:81-87.
26. Myrup B, Hansen P, Jensen T, et al.: 1995. Effect of low dose heparin on urinary albumin excretion in insulin dependent diabetes mellitus. Lancet 345:421-422.
27. Parving HH, Hommel E: 1989. Prognosis in diabetic nephropathy. BMJ 299:230-233.
28. Pettitt DJ, Saad MF, Bennett PH, Nelson RG, Kowler WC: 1990. Familial predisposition to renal disease in two generations of Pima Indians with type 2 (non-insulin dependent) diabetes mellitus. Diabetologia 33:438-443.
29. Pirart J: 1978. Diabetes mellitus and its degenerative complications: a prospective study of 4,400 patients observed between 1947 and 1973. Diabetes Care 1:168-188.
30. Raganathan S, Krempf M, Feraille E, Charbonnel B: 1993. Short term effect of an aldose reductase inhibitor on urinary albumin excretion rate (UAER) and glomerular filtration rate (GFR) in type 1 diabetic patients with incipient nephropathy. Diabete Met 19:257-261.
31. Schmidt S, Schone N, Ritz E: 1995. Association of ACE gene polymorphism and diabetic nephropathy? Kidney Int 47:1176-1181.
32. Seaquist ER, Goetz FC, Rich S, Barbosa J: 1989. Familial clustering of diabetic kidney disease: evidence of genetic susceptibility to diabetic nephropathy. N Engl J Med 320: 1161-1165.
33. Sharma K, Guo J, Jin Y, Ericksen M, Ziyadeh FN: 1994. Anti-TGF-β antibody attenuates renal hypertrophy and matrix expansion in diabetic mice [abst]. J Am Soc Nephrol 5:972.
34. Tamsma JT, Van den Born J, Bruijn J, et al.: 1994. Expression of glomerular extracellular matrix components in human diabetic nephropathy: decrease of heparan sulphate in glomerular basement membrane. Diabetologia 37:313-320.
35. Tarnow L, Cambien F, Rossing P, et al.: 1995. Insertion/deletion polymorphism in the angiotensin 1 converting enzyme gene is associated with coronary heart disease in IDDM patients with diabetic nephropathy. Diabetologia 38:798-803.
36. Viberti GC, Keen H, Wiseman MJ: 1985. Raised arterial pressure in parents of proteinuric insulin dependent diabetes. BMJ 295:515-517.
37. Vlassara H, Brownlee M, Manogue KR, Dinarello C, Pasagian A: 1988. Cachectin/ TNF and IL-1 induced by glucose modified proteins: role in normal tissue remodeling. Science 240:1546-1548.
38. Vlassara H, Striker LJ, Teichberg S, Fuh H, Li Y, Steffes M: 1994. Advanced glycosylation end products induce glomerulosclerosis and albuminuria in normal rats. Proc Natl Acad Sci USA 91:11,704-11,708.
39. Wolf G, Sharma K, Chen Y, Ericksen M, Ziyadeh FN: 1992. High glucose induced proliferation in mesangial cells is reversed by autocrine TGF-β. Kidney Int 42:747-656.
40. Zhang PL, MacKenzie HS, Troy JL, Brenner BM: 1994. Effects of atrial natriuretic peptide receptor antagonist on glomerular hyperfiltration in diabetic rats. J Am Soc Nephrol 4:1564-1570. TEM